'A decisive turning point,' says PM Modi as Oxford, Bharat Biotech’s Covid-19 vaccines get restricted emergency use approval

6 months ago 21
google news Flipboard

NEW DELHI: Prime Minister Narendra Modi on Sunday congratulated the nation and thanked the scientific and healthcare community after the Drugs Controller General of India (DCGI) gave the final approval to Oxford-AstraZeneca and Bharat Biotech’s Covid-19 vaccines for emergency use.
The announcement marks a “decisive turning point” in India’s fight against Covid-19 pandemic, PM Modi tweeted soon after the announcement.
"Every India would be proud that both vaccines are “made in India,” PM Modi said.
The DCGI today approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. The approval by the DCGI was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
“A decisive turning point to strengthen a spirited fight! DCGI granting approval to vaccines of Serum Institute of India and Bharat Biotech accelerates the road to a healthier and Covid free nation. Congratulations India. Congratulations to our hardworking scientists and innovators,” the PM said.
“It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion,” the prime minister said.
The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

FacebookTwitterLinkedinEMail

  1. Homepage
  2. India